tm logo

Monitor this mark

View On USPTO

ORAP
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 25 Jun 2024

Last Applicant/ Owned by

MYRIEL PHARMACEUTICALS, LLC

4th Floor

BRIDGEWATER

NJ

08807

Serial Number

97686278 filed on 21st Nov 2022

Registration Number

N/A

Correspondent Address

Mark A. Mazza

Mark A. Mazza Eckert Seamans Cherin & Mellott, LLC

PITTSBURGH, PA 15219

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ORAP

Prescription drugs being pharmaceutical preparations used for the treatment of Tourette's Syndrome

Classification Information

Class [005]
Pharmaceutical Products

Prescription drugs being pharmaceutical preparations used for the treatment of Tourette's Syndrome

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97686278

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 500879-00009

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
12th Dec 2024SOU TEAS EXTENSION RECEIVED
25th Jun 2024SOU EXTENSION 2 GRANTED
25th Jun 2024SOU EXTENSION 2 FILED
25th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25th Jun 2024SOU TEAS EXTENSION RECEIVED
24th Jun 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
24th Jun 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24th Jun 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16th Dec 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Dec 2023SOU EXTENSION 1 GRANTED